A new SARS-CoV-2 variant, Nimbus or NB.1.8.1, is drawing attention due to rising transmission in parts of Asia.

COVID is still with us, and there will be other pandemics. It’s critical that we don’t forget the lessons we’ve learned.” ...

Rapid diagnostics continue transforming healthcare delivery worldwide, fueled by aging populations, decentralized care models, technological converge ...

As respiratory illnesses like COVID-19, influenza, and Mycoplasma pneumonia continue to spread, the need for safe, non-pharmaceutical prevention options is growing. South Korea-based biotech firm LUCA ...

Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...

A contagious new COVID-19 variant called NB.1.8.1, aka "Nimbus," is now dominant in the United States, CDC data show. What to know about symptoms and vaccines.

A newly distinguished University of New Mexico professor discusses her clinical research and advocacy around Long COVID.

Since the emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), understanding the mechanisms underlying ...

SARS-CoV-2 articles from across Nature Portfolio SARS-CoV-2 is a positive-sense single-stranded RNA virus. It is contagious in humans and is the cause of the coronavirus disease 2019 (COVID-19).

An expert group from the World Health Organization failed to find a definitive answer to the COVID-19 pandemic’s origins in ...

Read the latest medical research on the prevention, management, and treatment of COVID-19 and the SARS-CoV-2 virus. This section also covers earlier related diseases, including SARS.

As international alerts emerge regarding a new variant of COVID-19, the Dominican Republic is experiencing a surge in virus ...